Figure 5From: Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient miceA: Volume of lamellar bodies per cell. B: Volume of lamellar bodies per lung. The content of lamellar bodies per cell and lung subsided significantly only after 6 weeks of treatment. A longer period of treatment led to a further decrease in lamellar body volume per lung but not per cell.Back to article page